Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 40.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 699 shares of the medical equipment provider’s stock after purchasing an additional 200 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Intuitive Surgical were worth $365,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Howard Capital Management Group LLC lifted its holdings in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after acquiring an additional 92 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after purchasing an additional 9,194 shares in the last quarter. Quest Partners LLC acquired a new stake in shares of Intuitive Surgical in the third quarter valued at about $173,000. Great Valley Advisor Group Inc. raised its holdings in shares of Intuitive Surgical by 2.7% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 2,543 shares of the medical equipment provider’s stock valued at $1,249,000 after buying an additional 66 shares during the period. Finally, Algert Global LLC acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $1,988,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on ISRG. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Truist Financial cut their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a report on Monday, March 17th. Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Robert W. Baird cut their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. Finally, Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $611.86.

Get Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $508.58 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The business has a 50 day simple moving average of $561.62 and a 200 day simple moving average of $532.25. The firm has a market capitalization of $181.15 billion, a P/E ratio of 79.34, a P/E/G ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.